Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acute liver failure (ALF) is a complicated clinical syndrome associated with high mortality, with liver transplantation as the only treatment option. Treatment of mesenchymal stem cells has shown a potential therapeutic option for acute liver failure. However, the lack of random clinical trials and large non-human primate studies makes it necessary to assess the efficacy and safety in the clinic. METHODS: We treated the monkeys with peripheral delivery of human umbilical MSCs (hUC-MSCs) and investigated the role of hUC-MSCs in modulating the progress of acute liver failure. RESULTS: The use of early peripheral infusion of human umbilical cord MSC infusion did not improve liver regeneration or modulate adaptive immunity. However, it significantly suppressed the hepatic aggregation and maturation of circulating monocytes and their IL-6 secretion, greatly improving liver histology, systemic homeostasis, and survival. CONCLUSIONS: Our study reveals the critical role of monocyte-derived IL-6 in initiating and accelerating acute liver failure and hUC-MSC treatment can disrupt the development of the inflammatory cascade by inhibiting monocyte activation. Early hUC-MSC treatment disrupts the development of the inflammatory cascade, indicating a potential clinical solution for acute liver failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Resveratrol stimulates AMP kinase activity in neurons
Dasgupta, B., & Milbrandt, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610068104 · Cited by 723
Interleukin 6 and liver regeneration
STREETZ, K. L., LUEDDE, T., MANNS, M. P., & TRAUTWEIN, C. (2000) · Gut · doi:10.1136/gut.47.2.309 · Cited by 238
Possamai, L. A., Thursz, M. R., Wendon, J. A., & Antoniades, C. G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.031 · Cited by 153
Cited by
Abbaszadeh, H., Ghorbani, F., Derakhshani, M., Movassaghpour, A., & Yousefi, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29004 · Cited by 188
“…the potential effects of hucMSCs in treatment of various diseases such as diabetes (Bi et al., 2018), cancer (Xiufeng Li & Li, 2019), and liver (Guo et al., 2019), bone (Day et al., 2018), cartilage (K.‐C. Wu, Chang, Liu, & Ding, 2019), brain (Tanaka et al., 2018), and cardiovascular (X. Li et…”
BackgroundZhou, Q., Rong, C., Gu, T., Li, H., Wu, L., Zhuansun, X., Zhao, X., Xiao, Z., Kuang, Y., Xu, S., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03030-8 · Cited by 43
Current understanding of mesenchymal stem cells in liver diseases
Wu, M.-C., & Meng, Q.-H. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i9.1349 · Cited by 29
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
Tao, Y.-C., & Chen, E.-Q. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.153 · Cited by 15
“The promising results of UC- MSCs have been observed in experimental animal models of liver cirrhosis and liver failure (52,53).”
BackgroundCell therapy for end-stage liver disease: Current state and clinical challenge
Zhang, L., Deng, Y., Bai, X., Wei, X., Ren, Y., Chen, S., & Deng, H. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003332 · Cited by 12
“[125] Additionally, the MSC-mediated inhibitory effect on the maturation of circulating monocytes and DCs depends on IL6 and HGF. [126,127] Moreover, evidence suggests that the inhibitory effect of MSCs on NK cells is attributed to PGE2, IDO, TGF-β 1, and NO secreted by MSCs. [128] Interestingly,…”
Metadata
- Authors
- Guo, G., Zhuang, X., Xu, Q., Wu, Z., Zhu, Y., Zhou, Y., Li, Y., Lu, Y., Zhang, B., Talbot, P., Liao, J., She, J., Bu, H., & Shi, Y.
- Venue
- Stem Cell Research & Therapy
- Published
- 2019-03-12
- Volume
- 10
- Issue
- 1
- Pages
- 84-84
- ISSN
- 1757-6512 (ISSN-L)
- OpenAlex
- W2940899807
- Cited by
- 47
- References
- 6
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys. https://app.cochat.ai/papers/10.1186/s13287-019-1184-2
- The paper
- Guo, G., Zhuang, X., Xu, Q., Wu, Z., Zhu, Y., Zhou, Y., Li, Y., Lu, Y., Zhang, B., Talbot, P., Liao, J., She, J., Bu, H., & Shi, Y. (2019). Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-019-1184-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.